24/7 Market News Snapshot 20 August, 2025 – Shineco, Inc. Common Stock (NASDAQ:SISI)

August 20, 2025

DENVER, Colo., 20 August, 2025 (www.247marketnews.com) – (NASDAQ:SISI) are discussed in this article.
Shineco, Inc. (NASDAQ:SISI) has recently witnessed an impressive surge in its stock price, currently trading at $6.214, marking a notable 25.54% increase from its previous close of $4.950. This upward trend in pre-market sessions reflects robust investor interest and a bullish sentiment surrounding the company, supported by a trading volume of 916.33K, indicating vigorous market activity and potential for further momentum. Analysts suggest that this positive trajectory may persist, making SISI an attractive option for investors capitalizing on the upward movement in the market.

In tandem with this burgeoning stock performance, Shineco has announced a strategic partnership with blockchain technology provider Plus Me Limited, set to transform the field of cell therapy. The new “Cellular Asset On-Chaining and Marketing Ecosystem Cooperation Agreement” aims to pioneer the tokenization of biological cellular assets, streamlining processes within the global cell therapy sector. The partnership will leverage blockchain technology to ensure secure and transparent custody of Shineco’s mesenchymal stem cells (MSCs) on the Ethereum mainnet. By utilizing smart contracts, this initiative will enhance ownership rights and provide unique non-fungible digital identifiers (NFDIs) for registered cellular assets, ensuring precise traceability.

Moreover, the introduction of “Cell Infusion Redemption Tokens” compliant with ERC-1400/ERC-20 will enhance access to Shineco’s Cell Therapy Centers, addressing key industry challenges such as cost barriers and product authenticity. This collaboration, reinforced by Shineco’s recent acquisition of a controlling stake in Xi’an Dong’ao Health Management Co., Ltd., fortifies the company’s infrastructure, allowing for fluid on-chain and off-chain asset settlements and the establishment of a global network for cell storage and infusion.

Jennifer Zhan, CEO of Shineco, emphasized that this innovative initiative not only marks a milestone in the biotechnological economy but also positions the company to redefine the commercial fabric of the biological cell industry for substantial growth and scalability.

Related news for (SISI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.